Follow
Ping Chi
Title
Cited by
Cited by
Year
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
18982017
Organoid cultures derived from patients with advanced prostate cancer
D Gao, I Vela, A Sboner, PJ Iaquinta, WR Karthaus, A Gopalan, ...
Cell 159 (1), 176-187, 2014
14362014
Covalent histone modifications—miswritten, misinterpreted and mis-erased in human cancers
P Chi, CD Allis, GG Wang
Nature reviews cancer 10 (7), 457-469, 2010
12792010
Chromatin remodeling and cancer, Part I: Covalent histone modifications
GG Wang, CD Allis, P Chi
Trends in molecular medicine 13 (9), 363-372, 2007
5332007
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
W Lee, S Teckie, T Wiesner, L Ran, CN Prieto Granada, M Lin, S Zhu, ...
Nature genetics 46 (11), 1227-1232, 2014
5252014
Synapsin dispersion and reclustering during synaptic activity
P Chi, P Greengard, TA Ryan
Nature neuroscience 4 (12), 1187-1193, 2001
4122001
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
C Lu, SU Jain, D Hoelper, D Bechet, RC Molden, L Ran, D Murphy, ...
Science 352 (6287), 844-849, 2016
3712016
Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies
P Chi, P Greengard, TA Ryan
Neuron 38 (1), 69-78, 2003
3512003
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
P Chi, Y Chen, L Zhang, X Guo, J Wongvipat, T Shamu, JA Fletcher, ...
Nature 467 (7317), 849-853, 2010
3392010
Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling
GG Wang, CD Allis, P Chi
Trends in molecular medicine 13 (9), 373-380, 2007
3272007
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
JY Blay, C Serrano, MC Heinrich, J Zalcberg, S Bauer, H Gelderblom, ...
The Lancet Oncology 21 (7), 923-934, 2020
3162020
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
Y Chen, P Chi, S Rockowitz, PJ Iaquinta, T Shamu, S Shukla, D Gao, ...
Nature medicine 19 (8), 1023-1029, 2013
3132013
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
AR Moore, E Ceraudo, JJ Sher, Y Guan, AN Shoushtari, MT Chang, ...
Nature genetics 48 (6), 675-680, 2016
2982016
Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: a phase 2 clinical trial
MA Dickson, GK Schwartz, ML Keohan, SP D’Angelo, MM Gounder, P Chi, ...
JAMA oncology 2 (7), 937-940, 2016
2822016
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ...
Cell 185 (3), 563-575. e11, 2022
2662022
Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST
CN Prieto-Granada, T Wiesner, JL Messina, AA Jungbluth, P Chi, ...
The American journal of surgical pathology 40 (4), 479-489, 2016
2372016
Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
T Wiesner, W Lee, AC Obenauf, L Ran, R Murali, QF Zhang, EWP Wong, ...
Nature 526 (7573), 453-457, 2015
2342015
Regulation of neurotransmitter release by synapsin III
J Feng, P Chi, TA Blanpied, Y Xu, AM Magarinos, A Ferreira, ...
Journal of Neuroscience 22 (11), 4372-4380, 2002
1822002
Roscovitine: a novel regulator of P/Q‐type calcium channels and transmitter release in central neurons
Z Yan, P Chi, J A. Bibb, T A. Ryan, P Greengard
The Journal of physiology 540 (3), 761-770, 2002
1622002
The management of metastatic GIST: current standard and investigational therapeutics
CM Kelly, L Gutierrez Sainz, P Chi
Journal of Hematology & Oncology 14 (1), 2, 2021
1432021
The system can't perform the operation now. Try again later.
Articles 1–20